Screener
Biohaven BHVN Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(130,532) | $(221,677) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 2,366 | 2,246 |
| Non-cash share-based compensation | 28,286 | 53,062 |
| Issuance of common shares as payment under license and other agreements | 858 | 4,844 |
| Change in fair value of forward contract and derivative liabilities | — | 3,610 |
| Change in fair value of notes payable | 3,012 | — |
| Other non-cash items, net | (837) | (2,844) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's stock-based comp?
- Biohaven (BHVN) reported stock-based comp of $28.29M in Q1 2026.
- How has Biohaven's stock-based comp changed year-over-year?
- Biohaven's stock-based comp decreased by 46.7% year-over-year, from $53.06M to $28.29M.
- What is the long-term trend for Biohaven's stock-based comp?
- Over 3 years (2022 to 2025), Biohaven's stock-based comp has grown at a -16.6% compound annual growth rate (CAGR), from $193.56M to $112.36M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Biohaven's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude